Clovis Oncology Receives $20,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e87ee22e-11c1-4dc2-9d19-f127d522851c&Preview=1
Date
6/3/2011
Company Name
Clovis Oncology
Mailing Address
2525 28th Street Boulder, CO 80301
Company Description
Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
Website
http://www.Clovisoncology.com
Transaction Type
Debt
Transaction Amount
$20,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include securities to be acquired upon exercise of option, warrants or other rights to acquire securities. Amount may also include convertible notes. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed